Cytophage Technologies Inc. is a Canadian private corporation that has an innovative template technology that uses synthetic biology to create tailor-made bacteriophage products that can bind to and kill bacterial cells. This technology has commercial applications in human health, animal health and food safety.
Cubresa has installed the first BrainPET Insert System at St. Joseph’s Health Care London, in partnership with the hospital’s research institute – Lawson Health Research Institute.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.
member